The pro-apoptotic protein, bik, exhibits potent antitumor activity that is dependent on its BH3 domain

Molecular Cancer Therapeutics

Volumn 1, Issue 2, 2001, Pages 95-102

  Tong, Yiai ^a   Yang, Quan ^a   Vater, Carol ^c   Venkatesh, L K ^b   Custeau, Dominique ^a   Chittenden, Thomas ^c   Chinnadurai, G ^b   Gourdeau, Henriette ^a  

^a Shire Canada   (Canada)

^b S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^c Apoptosis Technology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BIK PROTEIN, HUMAN; CASPASE; CYTOCHROME C; MEMBRANE PROTEIN; PROTEIN;

ADENOVIRUS; ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; COLON TUMOR; DRUG EFFECT; DRUG SCREENING; FEMALE; GENE VECTOR; GENETICS; HUMAN; MALE; METABOLISM; MITOCHONDRION; MOUSE; NICK END LABELING; NUDE MOUSE; PROSTATE TUMOR; PROTEIN TERTIARY STRUCTURE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CASPASES; CELL DIVISION; COLONIC NEOPLASMS; CYTOCHROME C GROUP; FEMALE; GENETIC VECTORS; HUMANS; IN SITU NICK-END LABELING; MALE; MEMBRANE PROTEINS; MICE; MICE, NUDE; MITOCHONDRIA; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035553918     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bellamy, C. O., Malcomson, R. D., Harrison, D. J., and Wyllie, A. H. Cell death in health and disease: the biology and regulation of apoptosis. Semin. Cancer Biol., 6: 3-16, 1995.
2. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993. (Pubitemid 23289454)
3. Reed, J. C. Mechanisms of apoptosis avoidance in cancer. Curr. Opin. Oncol., 11: 68-75, 1999. (Pubitemid 29082059)
4. Fisher, T. C., Milner, A. E., Gregory, C. D., Jackman, A. L., Aherne, G. W., Hartley, J. A., Dive, C., and Hickman, J. A. Bcl-2 Modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res., 53: 3321-3326, 1993. (Pubitemid 23223304)
5. Yin, X. M., Oltvai, Z. N., and Korsmeyer, S. J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (Lond.), 369: 321-323, 1994. (Pubitemid 24159542)
6. Ottilie, S., Diaz, J. L., Horne, W., Chang, J., Wang, Y., Wilson, G., Chang, S., Weeks, S., Fritz, L. C., and Oltersdorf, T. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J. Biol. Chem., 272: 30866-30872, 1997. (Pubitemid 27527529)
7. Chittenden, T., Flemington, C., Houghton, A. B., Ebb, R. G., Gallo, G. J., Elangovan, B., Chinnadurai, G., and Lutz, R. J. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J., 14: 5589-5596, 1995.
8. Zha, H., Aimé-Sempé, C., Sato, T., and Reed, J. C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem., 271: 7440-7444, 1996. (Pubitemid 26107015)
9. Wang, K., Gross, A., Waksman, G., and Korsmeyer, S. J. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing. Mol. Cell. Biol., 18: 6083-6089, 1998. (Pubitemid 28450559)
10. Holinger, E. P., Chittenden, T., and Lutz, R. J. Bak BH3 peptides antagonize Bcl-XL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem., 274: 13298-13304, 1999.
11. Wang, J-L., Zhang, Z-J., Choksi, S., Shan, S., Lu, Z., Croce, C. M., Alnemri, E. S., Korngold, R., and Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res., 60: 1498-1502, 2000. (Pubitemid 30183413)
12. Boyd, J. M., Gallo, G. J., Elangovan, B., Houghton, A. B., Malstrom, S., Avery, B. J., Ebb, R. G., Subramanian, T., Chittenden, T., Lutz, R. J., and Chinnadurai, G. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene, 11: 1921-1928, 1995.
13. Kawaga, S., Gu, J., Swisher, S. G., Ji, L., Roth, J. A., Lai, D., Stephens, C., and Fang, B. Antitumor effect of adenovirus-mediated BAX gene transfer on p53-sensitive and p53-resistant cancer lines. Cancer Res., 60: 1157-1161, 2000. (Pubitemid 30151973)
14. Li, X., Marani, M., Yu, J., Nan, B., Roth, J. A., Kagawa, S., Fang, B., Denner, L., and Marcelli, M. Adenovirus-mediated bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Cancer Res., 61: 186-191, 2001. (Pubitemid 32095716)
15. Pataer, A., Fang, B., Yu, R., Kagawa, S., Hunt, K. K., McDonnell, T. J., Roth, J. A., and Swisher, S. G. Adenoviral Bak overexpression mediates caspase-dependent tumor killing. Cancer Res., 60: 788-792, 2000. (Pubitemid 30129502)
16. Elangovan, B., and Chinnadurai, G. Functional dissection of the proapoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death. J. Biol. Chem., 272: 24494-24498, 1997. (Pubitemid 27418660)
17. Eskes, R., Desagher, S., Antonsson, B., and Martinou, J-C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol., 20: 929-935, 2000. (Pubitemid 30044230)
18. Tong, Y., Quirion, R., and Shen, S. H. Cloning and characterization of a novel mammalian PP2C isozyme. J. Biol. Chem., 273: 35282-35290, 1998. (Pubitemid 29028236)
19. Gorczyca, W., Gong, J., and Darzynkiewicz, Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53: 1945-1951, 1993. (Pubitemid 23127129)
20. Liu, X., Kum, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extracts: requirements for dATP and cytochrome C. Cell, 86: 147-157, 1996. (Pubitemid 26256586)
21. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Wash. DC), 275: 1132-1136, 1997. (Pubitemid 27097313)
22. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. Cytochrome c and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997. (Pubitemid 27508237)
23. Nicholson, D. W., and Thornberry, N. A. Caspases: killer proteases. Trends Biochem. Sci., 22: 299-306, 1997. (Pubitemid 27327087)
24. Wolf, B. B., and Green, D. R. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J. Biol. Chem., 274: 20049-20052, 1999.
25. Salvesen, G. S., and Dixit, V. M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci., 96: 10964-10967, 1999. (Pubitemid 29487313)
26. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993. (Pubitemid 23267698)
27. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994. (Pubitemid 24300618)
28. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, S., Beidler, D. R., Salvesen, G. S., and Dixit, V. M. Yama/CPP32 β, a mammalian homolog of CED-3, is a Crm inhibitable protease that cleaves the death substrate poly (ADP polymerase). Cell, 2: 801-809, 1995.
29. Tai, Y. T., Strobel, T., Kufe, D., and Cannistra, S. A. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. Cancer Res., 59: 2121-2126, 1999. (Pubitemid 29217675)
30. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Guild, B. C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature (Lond.), 374: 733-736, 1995.
31. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993. (Pubitemid 23259742)
32. Zha, J., Harada, H., Osipov, K., Jockel, J., Waksman, G., and Korsmeyer, S. J. BH3 domain of Bad is required for heterodimerization with Bcl-XL and pro-apoptotic activity. J. Biol. Chem., 272: 24101-24104, 1997. (Pubitemid 27418599)
33. Kelekar, A., Chang, B. S., Harlan, J. E., Fesik, S. W., and Thompson, C. B. Bad is a BH3 domain-continuing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell. Biol., 17: 7040-7046, 1997. (Pubitemid 27505933)
34. Wang, K., Yin, X-M., Chao, D. T., Milliman, C. L., and Korsmeyer, S. J. BID: a novel BH3 domain-only death agonist. Genes Dev., 10: 2859-2869, 1996. (Pubitemid 26394246)
35. Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N. Noxa, a BH3-only member of the bcl-2 family and candidate mediator of p53-induced apoptosis. Science (Wash. DC), 288: 1053-1058, 2000. (Pubitemid 30324238)
36. Orth, K., and Dixit, V. M. Bik and Bak induce apoptosis downstream of CrmA but upstream of inhibitor of apoptosis. J. Biol. Chem., 272: 8841-8844, 1997. (Pubitemid 27154873)
37. Mulvihill, S., Warren, R., Venook, A., Adler, A., Randlev, B., Heise, C., and Kim, D. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther., 8: 308-315, 2001. (Pubitemid 32237064)
38. Wodarz, D. Viruses as antitumor weapons defining conditions for tumor remission. Cancer Res., 61: 3501-3507, 2001. (Pubitemid 32695047)
39. Rainov, N. G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther., 11: 2389-2401, 2000.
40. Singhal, S., and Kaiser, L. R. Cancer chemotherapy using suicide genes. Surg. Oncol. Clin. N. Am., 7: 505-536, 1998. (Pubitemid 28354314)
41. Liu, T. J., el-Naggar, A. K., McDonnell, T. J., Steck, K. D., Wang, M., Taylor, D. L., and Clayman, G. L. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55: 3117-3122, 1995.
42. Marcelli, M., Marani, M., Li, X., Sturgis, L., Haidacher, S. J., Trial, J-A., Mannucci, R., Nicoletti, I., and Denner, L. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation. Prostate, 42: 260-273, 2000. (Pubitemid 30104569)
43. Wang, X. Z., Beebe, J. R., Pwiti, L., Bielawska, A., and Smyth, M. J. Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy. Cancer Res., 59: 5842-5848, 1999.
44. Okuno, S., Harada, M., Yano, T., Yano, S., Kiuchi, S., Tsuda, N., Sakamura, Y., Imai, J., Kawaguchi, T., and Tsujihara, K. Complete regression of xenografted human carcinomas by camptothecin analogue-carboxymethyl dextran conjugate (T-0128). Cancer Res., 60: 2988-2995, 2000.
45. Hopkinson-Woolley, J., Hughes, D., Gordon, S., and Martin, P. Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J. Cell Sci., 107: 1159-1167, 1994. (Pubitemid 24177317)